CFP and triple-A syndrome: In their study, Zhou et al.99 complemented a properdin‐deficient mouse (protected from AAA development) by injection of either wildtype Factor B or Factor B containing the gain‐of‐function mutation D276G that produces a stable convertase without the need for properdin.